Table 3.
Age | EC annual incidence | EC annual incidence for LGIN | EC detection rate | LGIN detection rate | EC-related mortality | All-cause mortality |
---|---|---|---|---|---|---|
40–44 | 1.36 | 4.96 | 16.92 | 130.56 | 0.68 | 122.41 |
45–49 | 4.90 | 17.68 | 70.65 | 545.00 | 2.19 | 184.60 |
50–54 | 9.93 | 34.95 | 193.45 | 1492.33 | 7.57 | 343.55 |
55–59 | 25.41 | 84.00 | 518.59 | 4000.54 | 14.87 | 475.18 |
60–64 | 35.48 | 108.02 | 976.17 | 7530.48 | 22.03 | 738.42 |
65–69 | 46.25 | 118.02 | 2072.48 | 15,987.72 | 33.08 | 1262.28 |
70–74 | 63.97 | 163.22 | – | – | 53.42 | 2380.26 |
75–79 | 64.45 | 164.36 | – | – | 65.73 | 4094.67 |
One-way sensitivity analysis values ± 20%; beta distribution was assumed for probability sensitivity analysis